Published on 8 May 2024 on GuruFocus.com via Yahoo Finance
Organogenesis Holdings Inc. Reports First Quarter 2024 Results: A Close Look at Financial ...
Revenue: Reported $110.0 million, an increase of 2.3% year-over-year, exceeding the estimate of $101.05 million.Net Loss: Recorded at $2.1 million, an improvement from a loss of $3.0 million in the previous year, and better than the estimated loss of $3.60 million.Earnings Per Share (EPS): Reported at -$0.02, surpassing the estimated EPS of -$0.03.Advanced Wound Care Revenue: Increased by 3% to $103.9 million, driving the overall revenue growth.Surgical & Sports Medicine Revenue: Declined by 9% to $6.1 million, reflecting challenges in this segment.Operating Expenses: Slightly increased to $85.1 million from $85.0 million, maintaining nearly consistent spending year-over-year.Adjusted EBITDA: Decreased to $2.6 million from $3.8 million in the previous year, indicating a drop in profitability.
Warning! GuruFocus has detected 4 Warning Sign with ORGO.